VICTOZA

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VICTOZA contains one active pharmaceutical ingredient (API):

1 Liraglutide UNII 839I73S42A - LIRAGLUTIDE

Liraglutide is a GLP-1 analogue with 97% sequence homology to human GLP-1 that binds to and activates the GLP-1 receptor. The GLP-1 receptor is the target for native GLP-1, an endogenous incretin hormone that potentiates glucose-dependent insulin secretion from the pancreatic beta cells. Unlike native GLP-1, liraglutide has a pharmacokinetic and pharmacodynamic profile in humans suitable for once daily administration. Read about Liraglutide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VICTOZA Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BJ02	Liraglutide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526602302159211
Country: CA	Health Products and Food Branch	Identifier(s): 02351064
Country: EE	Ravimiamet	Identifier(s): 1426834, 1426845, 1426856, 1426867, 1426878
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09529002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 050365, 080629
Country: FR	Base de données publique des médicaments	Identifier(s): 62645506
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 158587, 158590, 369047, 377090
Country: HK	Department of Health Drug Office	Identifier(s): 61180
Country: IE	Health Products Regulatory Authority	Identifier(s): 13221, 47980, 47981, 47989
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6292
Country: IT	Agenzia del Farmaco	Identifier(s): 039365010, 039365022
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499410G1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1050600, 1050601, 1050602, 1050603, 1050604
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 91634
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13616
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100213307
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54586001, W54586002, W54586003, W54586004, W54586005
Country: SG	Health Sciences Authority	Identifier(s): 13905P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5993111
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676950881, 8699676950928, 8699676950935, 8699676950942, 8699676950959
Country: US	FDA, National Drug Code	Identifier(s): 0169-4060, 50090-4503
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/21.13/0781